Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies
- 1 May 2019
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 33 (10) , 2522-2553
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patientsLeukemia, 2018
- Cytogenetic findings in WHO‐defined polycythaemia vera and their prognostic relevanceBritish Journal of Haematology, 2017
- ISCN 20162016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyLeukemia, 2013
- A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentBlood, 2012
- Application of Thrombolytic Drugs on Clotted Blood and Bone Marrow Specimens to Generate Usable Cells for Cytogenetic AnalysesArchives of Pathology & Laboratory Medicine, 2011
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)Blood, 2010
- Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significanceEuropean Journal of Haematology, 2009
- The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disordersCancer Genetics and Cytogenetics, 1985